Enoxacin is an oral fluoroquinolone antibacterial agent that was shown to enhance TRBP/DICER dependent miRNA maturation26, leading to tumor regression27,28 and EWS tumor stem cell depletion29,30. The gene discussed is DICER1; the disease is neoplasm.